These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 26331364

  • 1. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study.
    Rosenlund S, Hansen TW, Andersen S, Rossing P.
    Diabet Med; 2015 Nov; 32(11):1445-52. PubMed ID: 26331364
    [Abstract] [Full Text] [Related]

  • 2. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
    Pickup JC, Kidd J, Burmiston S, Yemane N.
    Diabetes Metab Res Rev; 2006 Nov; 22(3):232-7. PubMed ID: 16389648
    [Abstract] [Full Text] [Related]

  • 3. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J, McKay A, Ridyard C, Thornborough K, Bedson E, Peak M, Didi M, Annan F, Gregory JW, Hughes D, Gamble C.
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [Abstract] [Full Text] [Related]

  • 4. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Reid LJ, Gibb FW, Colhoun H, Wild SH, Strachan MWJ, Madill K, Dhillon B, Forbes S.
    Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
    [Abstract] [Full Text] [Related]

  • 5. Effect of Sensor-Augmented Pump Treatment Versus Multiple Daily Injections on Albuminuria: A 1-Year Randomized Study.
    Rosenlund S, Hansen TW, Rossing P, Andersen S.
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4181-8. PubMed ID: 26390102
    [Abstract] [Full Text] [Related]

  • 6. The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis.
    Sharma D, Morrison G, Joseph F, Purewal TS, Weston PJ.
    Diabetologia; 2011 Nov; 54(11):2768-70. PubMed ID: 21842427
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [Abstract] [Full Text] [Related]

  • 9. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.
    Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, Vogel C, Rosenbauer J, Holl RW, German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy.
    Diabet Med; 2008 Jan; 25(1):80-5. PubMed ID: 18199134
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.
    Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB, 5-Nations Study Group.
    Diabet Med; 2006 Feb; 23(2):141-7. PubMed ID: 16433711
    [Abstract] [Full Text] [Related]

  • 16. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M.
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [Abstract] [Full Text] [Related]

  • 17. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.
    Scott ES, McGrath RT, Januszewski AS, Calandro D, Hardikar AA, O'Neal DN, Fulcher G, Jenkins AJ.
    BMJ Open; 2019 Dec 29; 9(12):e033059. PubMed ID: 31888933
    [Abstract] [Full Text] [Related]

  • 18. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy.
    Bell DS, Ovalle F.
    Endocr Pract; 2000 Dec 29; 6(5):357-60. PubMed ID: 11141585
    [Abstract] [Full Text] [Related]

  • 19. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
    Rosenlund S, Theilade S, Hansen TW, Andersen S, Rossing P.
    Acta Diabetol; 2014 Dec 29; 51(6):955-62. PubMed ID: 25274393
    [Abstract] [Full Text] [Related]

  • 20. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A, Bozzetto L, Franco L, Riccardi G, Rivellese AA, Annuzzi G.
    Nutr Metab Cardiovasc Dis; 2019 Oct 29; 29(10):1110-1117. PubMed ID: 31371264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.